Six-month prescription-filling rates for secondary-prevention drugs in post-CABG VA patients were generally high, with antithrombotic-filling rates averaging 88.5%.
Observational (n=8,925)
Yes
Prescription-filling rates for secondary prevention medications post-CABG in VA facilities are high and increasing, indicating good compliance with cardiovascular prevention guidelines.
PURPOSE: The six-month prescription-filling rates for key secondary-prevention drugs in Department of Veterans Affairs (VA) patients who had undergone coronary artery bypass grafting (CABG) were studied. METHODS: Patient records for elective CABG from April 2000 through March 2002 (divided into four six-month periods) were analyzed. The study population included 8925 CABG-only patients surviving to hospital discharge. For each six-month period and in aggregate, the primary study endpoint was the six-month prescription-filling rate. RESULTS: Across the four six-month periods, prescription-filling rates increased for all categories of medications studied. There were modest progressive increases for lipid-lowering agents, statins, -blockers, angiotensin-converting-enzyme Inhibitors, and angiotensin-receptor blockers. The antithrombotic-filling rate averaged 88.5%. Filling rates for aspirin were much higher than for aspirin alternatives. CONCLUSION: Prescription-filling rates for post-CABG medications in VA facilities were generally high and suggested compliance with guidelines for the prevention of cardiovascular events.
Huang et al. (Tue,) conducted a observational in Coronary artery bypass grafting (CABG) (n=8,925). Secondary-prevention drugs was evaluated on Six-month prescription-filling rate. Six-month prescription-filling rates for secondary-prevention drugs in post-CABG VA patients were generally high, with antithrombotic-filling rates averaging 88.5%.